We identified several key molecular mechanisms, including the role of senescent cancer cell-expressed HLA-E in impairing NK cell cytotoxicity and reducing the recruitment of cDC1, leading to a diminished population of this critical antigen-presenting cell subset. This evidence concerns the gene HLA-E and cancer.